AstraZeneca: Strategic Transformation Dr Diagram

失败与踩坑

• When rejecting Pfizer's acquisition in 2…
• The COVID vaccine faced suspensions in m…
• Certain early oncology clinical trials f…

关键成功要素

• Soriot firmly rejected Pfizer's acquisit…
• Osimertinib became the first oncology bl…
• Farxiga expanded from diabetes drugs int…
• 39%
• Intense approvals of multiple oncology a…

经验教训

• Under acquisition pressure
• The success of oncology drugs relies on …
• Emerging market expansion is not about l…
• The COVID vaccine exposed execution weak…
• Facing a patent cliff

Workflow diagram • Built with Archify • Create yours ↗ • Hover to trace • R route • Click to focus • +/− zoom • M radar • T theme • E export